1. Market Research
  2. > Pharmaceutical Market Trends
  3. > United States Drugs for Respiratory Syncytial Virus (RSV) Industry 2015 Market Research Report

Summary

The United States Drugs for Respiratory Syncytial Virus (RSV) Industry 2015 Market Research Report is a professional and in-depth study on the current state of the Drugs for Respiratory Syncytial Virus (RSV) industry.

The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Drugs for Respiratory Syncytial Virus (RSV) market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status.

Development policies and plans are discussed as well as manufacturing processes and Bill of Materials cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins.

The report focuses on United States major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information. Upstream raw materials and equipment and downstream demand analysis is also carried out. The Drugs for Respiratory Syncytial Virus (RSV) industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered.

With 156 tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.


Table Of Contents

United States Drugs for Respiratory Syncytial Virus (RSV) Industry 2015 Market Research Report
Table of Contents

1 Industry Overview
1.1 Definition and Specifications of Drugs for Respiratory Syncytial Virus (RSV)
1.2 Classification of Drugs for Respiratory Syncytial Virus (RSV)
1.3 Applications of Drugs for Respiratory Syncytial Virus (RSV)
1.4 Industry Chain Structure of Drugs for Respiratory Syncytial Virus (RSV)
1.5 Industry Overview of Drugs for Respiratory Syncytial Virus (RSV)
1.6 Industry Policy Analysis of Drugs for Respiratory Syncytial Virus (RSV)
1.7 Industry News Analysis of Drugs for Respiratory Syncytial Virus (RSV)

2 Manufacturing Cost Structure Analysis of Drugs for Respiratory Syncytial Virus (RSV)
2.1 Bill of Materials (BOM) of Drugs for Respiratory Syncytial Virus (RSV)
2.2 BOM Price Analysis of Drugs for Respiratory Syncytial Virus (RSV)
2.3 Labor Cost Analysis of Drugs for Respiratory Syncytial Virus (RSV)
2.4 Depreciation Cost Analysis of Drugs for Respiratory Syncytial Virus (RSV)
2.5 Manufacturing Cost Structure Analysis of Drugs for Respiratory Syncytial Virus (RSV)
2.6 Manufacturing Process Analysis of Drugs for Respiratory Syncytial Virus (RSV)
2.7 China Price, Cost and Gross of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015

3 Technical Data and Manufacturing Plants Analysis
3.1 Capacity and Commercial Production Date of United States Key Manufacturers in 2014
3.2 Manufacturing Plants Distribution of United States Key Drugs for Respiratory Syncytial Virus (RSV) Manufacturers in 2014
3.3 RandD Status and Technology Source of United States Drugs for Respiratory Syncytial Virus (RSV) Key Manufacturers in 2014
3.4 Raw Materials Sources Analysis of United States Drugs for Respiratory Syncytial Virus (RSV) Key Manufacturers in 2014

4 Production Analysis of Drugs for Respiratory Syncytial Virus (RSV) by Regions, Type, and Applications
4.1 United States Production of Drugs for Respiratory Syncytial Virus (RSV) by Regions 2010-2015
4.2 United States Production of Drugs for Respiratory Syncytial Virus (RSV) by Type 2010-2015
4.3 United States Sales of Drugs for Respiratory Syncytial Virus (RSV) by Applications 2010-2015
4.4 Price Analysis of United States Drugs for Respiratory Syncytial Virus (RSV) Key Manufacturers in 2015
4.5 United States Capacity, Production, Import, Export, Sales, Price, Cost and Revenue of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015

5 Consumption Volume and Consumption Value Analysis of Drugs for Respiratory Syncytial Virus (RSV) by Regions
5.1 United States Consumption Volume of Drugs for Respiratory Syncytial Virus (RSV) by Regions 2010-2015
5.2 United States Consumption Value of Drugs for Respiratory Syncytial Virus (RSV) by Regions 2010-2015
5.3 United States Consumption Price Analysis of Drugs for Respiratory Syncytial Virus (RSV) by Regions 2010-2015

6 Analysis of Drugs for Respiratory Syncytial Virus (RSV) Production, Supply, Sales and Market Status 2010-2015
6.1 Capacity, Production, Sales, and Revenue of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015
6.2 Production Market Share and Sales Market Share Analysis of Drugs for Respiratory Syncytial Virus (RSV) 2014-2015
6.3 Sales Overview of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015
6.4 Supply, Consumption and Gap of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015
6.5 Import, Export and Consumption of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015
6.6 Cost, Price, Revenue and Gross Margin of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015

7 Analysis of Drugs for Respiratory Syncytial Virus (RSV) Industry Key Manufacturers
7.1 Ablynx NV
7.1.1 Company Profile
7.1.2 Product Picture and Specification
7.1.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.1.4 Ablynx NV SWOT Analysis

7.2 ADMA Biologics
7.2.1 Company Profile
7.2.2 Product Picture and Specification
7.2.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.2.4 ADMA Biologics SWOT Analysis

7.3 Agilvax
7.3.1 Company Profile
7.3.2 Product Picture and Specification
7.3.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.3.4 Agilvax SWOT Analysis

7.4 AlphaVax
7.4.1 Company Profile
7.4.2 Product Picture and Specification
7.4.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.4.4 AlphaVax SWOT Analysis

7.5 AmVac
7.5.1 Company Profile
7.5.2 Product Picture and Specification
7.5.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.5.4 AmVac SWOT Analysis

7.6 Aridis Pharmaceuticals
7.6.1 Company Profile
7.6.2 Product Picture and Specification
7.6.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.6.4 Aridis Pharmaceuticals SWOT Analysis

7.7 Artificial Cell Technologies
7.7.1 Company Profile
7.7.2 Product Picture and Specification
7.7.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.7.4 Artificial Cell Technologies SWOT Analysis

7.8 Astellas Pharma
7.8.1 Company Profile
7.8.2 Product Picture and Specification
7.8.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.8.4 Astellas Pharma SWOT Analysis

7.9 AstraZeneca
7.9.1 Company Profile
7.9.2 Product Picture and Specification
7.9.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.9.4 AstraZeneca SWOT Analysis

7.10 Bavarian Nordic
7.10.1 Company Profile
7.10.2 Product Picture and Specification
7.10.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.10.4 Bavarian Nordic SWOT Analysis

7.11 Biota Pharmaceuticals
7.11.1 Company Profile
7.11.2 Product Picture and Specification
7.11.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.11.4 Biota Pharmaceuticals SWOT Analysis

7.12 Celltrion
7.12.1 Company Profile
7.12.2 Product Picture and Specification
7.12.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.12.4 Celltrion SWOT Analysis

7.13 Codagenix
7.13.1 Company Profile
7.13.2 Product Picture and Specification
7.13.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.13.4 Codagenix SWOT Analysis

7.14 Crucell
7.14.1 Company Profile
7.14.2 Product Picture and Specification
7.14.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.14.4 Crucell SWOT Analysis

7.15 CureVac
7.15.1 Company Profile
7.15.2 Product Picture and Specification
7.15.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.15.4 CureVac SWOT Analysis

7.16 Emergent BioSolutions
7.16.1 Company Profile
7.16.2 Product Picture and Specification
7.16.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.16.4 Emergent BioSolutions SWOT Analysis

7.17 Roche
7.17.1 Company Profile
7.17.2 Product Picture and Specification
7.17.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.17.4 Roche SWOT Analysis

7.18 GenVec
7.18.1 Company Profile
7.18.2 Product Picture and Specification
7.18.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.18.4 GenVec SWOT Analysis

7.19 Gilead Sciences
7.19.1 Company Profile
7.19.2 Product Picture and Specification
7.19.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.19.4 Gilead Sciences SWOT Analysis

7.20 GlaxoSmithKline
7.20.1 Company Profile
7.20.2 Product Picture and Specification
7.20.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.20.4 GlaxoSmithKline SWOT Analysis

7.21 Humabs BioMed
7.21.1 Company Profile
7.21.2 Product Picture and Specification
7.21.3 Capacity, Production, Price, Cost, Gross, and Revenue
7.21.4 Humabs BioMed SWOT Analysis

8 Price and Gross Margin Analysis
8.1 Analysis of Price
8.2 Gross Margin Analysis
8.3 Price Comparison by Regions
8.4 Price Analysis of Different Drugs for Respiratory Syncytial Virus (RSV) Product Types
8.5 Market Share Analysis of Different Drugs for Respiratory Syncytial Virus (RSV) Price Levels
8.6 Gross Margin Analysis of Different Drugs for Respiratory Syncytial Virus (RSV) Applications

9 Marketing Trader or Distributor Analysis of Drugs for Respiratory Syncytial Virus (RSV)
9.1 Marketing Channels Status of Drugs for Respiratory Syncytial Virus (RSV)
9.2 Traders or Distributors of Drugs for Respiratory Syncytial Virus (RSV) with Contact Information
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Drugs for Respiratory Syncytial Virus (RSV)
9.4 United States Import, Export and Trade Analysis of Drugs for Respiratory Syncytial Virus (RSV)

10 Development Trend of Drugs for Respiratory Syncytial Virus (RSV) Industry 2016-2021
10.1 Capacity and Production Overview of Drugs for Respiratory Syncytial Virus (RSV) 2016-2021
10.2 Production Market Share by Product Types of Drugs for Respiratory Syncytial Virus (RSV) 2016-2021
10.3 Sales and Sales Revenue Overview of Drugs for Respiratory Syncytial Virus (RSV) 2016-2021
10.4 United States Sales of Drugs for Respiratory Syncytial Virus (RSV) by Applications 2016-2021
10.5 Import, Export and Consumption of Drugs for Respiratory Syncytial Virus (RSV) 2016-2021
10.6 Cost, Price, Revenue and Gross Margin of Drugs for Respiratory Syncytial Virus (RSV) 2016-2021

11 Industry Chain Suppliers of Drugs for Respiratory Syncytial Virus (RSV) with Contact Information
11.1 Major Raw Materials Suppliers of Drugs for Respiratory Syncytial Virus (RSV) with Contact Information
11.2 Manufacturing Equipment Suppliers of Drugs for Respiratory Syncytial Virus (RSV) with Contact Information
11.3 Major Players of Drugs for Respiratory Syncytial Virus (RSV) with Contact Information
11.4 Key Consumers of Drugs for Respiratory Syncytial Virus (RSV) with Contact Information
11.5 Supply Chain Relationship Analysis of Drugs for Respiratory Syncytial Virus (RSV)

12 New Project Investment Feasibility Analysis of Drugs for Respiratory Syncytial Virus (RSV)
12.1 New Project SWOT Analysis of Drugs for Respiratory Syncytial Virus (RSV)
12.2 New Project Investment Feasibility Analysis of Drugs for Respiratory Syncytial Virus (RSV)

13 Conclusion of the United States Drugs for Respiratory Syncytial Virus (RSV) Industry 2015 Market Research Report




List of Tables and Figures

Figure Picture of Drugs for Respiratory Syncytial Virus (RSV)
Table Product Specifications of Drugs for Respiratory Syncytial Virus (RSV)
Table Classification of Drugs for Respiratory Syncytial Virus (RSV)
Figure United States Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Product Types in 2014
Table Applications of Drugs for Respiratory Syncytial Virus (RSV)
Figure United States Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Applications in 2014
Figure Industry Chain Structure of Drugs for Respiratory Syncytial Virus (RSV)
Table United States Industry Overview of Drugs for Respiratory Syncytial Virus (RSV)
Table Industry Policy of Drugs for Respiratory Syncytial Virus (RSV)
Table Industry News List of Drugs for Respiratory Syncytial Virus (RSV)
Table Bill of Materials (BOM) of Drugs for Respiratory Syncytial Virus (RSV)
Table Bill of Materials (BOM) Price of Drugs for Respiratory Syncytial Virus (RSV)
Table Labor Cost of Drugs for Respiratory Syncytial Virus (RSV)
Table Depreciation Cost of Drugs for Respiratory Syncytial Virus (RSV)
Table Manufacturing Cost Structure Analysis of Drugs for Respiratory Syncytial Virus (RSV) in 2014
Figure Manufacturing Process Analysis of Drugs for Respiratory Syncytial Virus (RSV)
Table United States Price Analysis of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015 (USD/Dose)
Table United States Cost Analysis of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015 (USD/Dose)
Table United States Gross Analysis of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015
Table Capacity (Doses) and Commercial Production Date of United States Drugs for Respiratory Syncytial Virus (RSV) Key Manufacturers in 2014
Table Manufacturing Plants Distribution of United States Key Drugs for Respiratory Syncytial Virus (RSV) Manufacturers in 2014
Table RandD Status and Technology Source of United States Drugs for Respiratory Syncytial Virus (RSV) Key Manufacturers in 2014
Table Raw Materials Sources Analysis of United States and United States Drugs for Respiratory Syncytial Virus (RSV) Key Manufacturers in 2014
Table United States Production of Drugs for Respiratory Syncytial Virus (RSV) by Regions 2010-2015 (Doses)
Table United States Production Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Regions 2010-2015
Figure United States Production Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Regions in 2014
Figure United States Production Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Regions in 2015
Table United States Production of Drugs for Respiratory Syncytial Virus (RSV) by Types in 2010-2015 (Doses)
Table United States Production Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type in 2010-2015
Figure United States Production Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type in 2014
Figure United States Production Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type in 2015
Table United States Sales of Drugs for Respiratory Syncytial Virus (RSV) by Applications 2010-2015 (Doses)
Table United States Production Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Applications 2010-2015
Figure United States Production Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Applications in 2014
Figure United States Production Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Applications in 2015
Table Price Comparison of United States Drugs for Respiratory Syncytial Virus (RSV) Key Manufacturers in 2015 (USD/Dose)
Table United States Capacity, Production, Import Export Sales Price , Cost and Revenue (M USD) of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015
Table United States Consumption Volume of Drugs for Respiratory Syncytial Virus (RSV) by Regions 2010-2015 (Doses)
Table United States Consumption Volume Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Regions 2010-2015
Figure United States Consumption Volume Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Regions in 2014
Figure United States Consumption Volume Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Regions in 2015
Table United States Consumption Value of Drugs for Respiratory Syncytial Virus (RSV) by Regions 2010-2015 (M USD)
Table United States Consumption Value Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Regions 2010-2015
Figure United States Consumption Value Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Regions in 2014
Figure United States Consumption Value Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Regions in 2015
Table Consumption Price of Drugs for Respiratory Syncytial Virus (RSV) by Regions 2010-2015 (USD/Dose)
Table United States and Major Manufacturers Capacity of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015 (Doses)
Table United States Capacity Market Share of Major Drugs for Respiratory Syncytial Virus (RSV) Manufacturers 2010-2015
Table United States and Major Manufacturers Production of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015 (Doses)
Table United States Production Market Share of Major Drugs for Respiratory Syncytial Virus (RSV) Manufacturers 2010-2015
Table United States and Major Manufacturers Sales of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015 (Doses)
Table United States Sales Market Share of Major Drugs for Respiratory Syncytial Virus (RSV) Manufacturers 2010-2015
Table United States and Major Manufacturers Sales Revenue of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015 (M USD)
Table United States Sales Revenue Market Share of Major Drugs for Respiratory Syncytial Virus (RSV) Manufacturers 2010-2015
Figure United States Capacity (Doses), Production (Doses) and Growth Rate of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015
Figure United States Capacity Utilization Rate of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015
Figure United States Sales Revenue (M USD) and Growth Rate of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015
Figure United States Production Market Share of Major Drugs for Respiratory Syncytial Virus (RSV) Manufacturers in 2014
Figure United States Production Market Share of Major Drugs for Respiratory Syncytial Virus (RSV) Manufacturers in 2015
Figure United States Sales Market Share of Major Drugs for Respiratory Syncytial Virus (RSV) Manufacturers in 2014
Figure United States Sales Market Share of Major Drugs for Respiratory Syncytial Virus (RSV) Manufacturers in 2015
Figure United States Sales (Doses) and Growth Rate of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015
Table United States Supply, Consumption and Gap of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015 (Doses)
Table United States Import, Export and Consumption of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015 (Doses)
Table Price of United States Drugs for Respiratory Syncytial Virus (RSV) Major Manufacturers 2010-2015 (USD/Dose)
Table Gross Margin of United States Drugs for Respiratory Syncytial Virus (RSV) Major Manufacturers 2010-2015
Table United States and Major Manufacturers Revenue of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015 (M USD)
Table United States Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Revenue (M USD) and Gross Margin of Drugs for Respiratory Syncytial Virus (RSV) 2010-2015
Table Ablynx NV Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Ablynx NV
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Ablynx NV 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of Ablynx NV 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of Ablynx NV 2010-2015
Table Ablynx NV Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table ADMA Biologics Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of ADMA Biologics
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of ADMA Biologics 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of ADMA Biologics 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of ADMA Biologics 2010-2015
Table ADMA Biologics Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table Agilvax Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Agilvax
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Agilvax 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of Agilvax 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of Agilvax 2010-2015
Table Agilvax Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table AlphaVax Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of AlphaVax
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of AlphaVax 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of AlphaVax 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of AlphaVax 2010-2015
Table AlphaVax Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table AmVac Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of AmVac
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of AmVac 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of AmVac 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of AmVac 2010-2015
Table AmVac Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table Aridis Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Aridis Pharmaceuticals
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Aridis Pharmaceuticals 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of Aridis Pharmaceuticals 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of Aridis Pharmaceuticals 2010-2015
Table Aridis Pharmaceuticals Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table Artificial Cell Technologies Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Artificial Cell Technologies
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Artificial Cell Technologies 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of Artificial Cell Technologies 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of Artificial Cell Technologies 2010-2015
Table Artificial Cell Technologies Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table Astellas Pharma Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Astellas Pharma
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Astellas Pharma 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of Astellas Pharma 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of Astellas Pharma 2010-2015
Table Astellas Pharma Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table AstraZeneca Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of AstraZeneca
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of AstraZeneca 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of AstraZeneca 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of AstraZeneca 2010-2015
Table AstraZeneca Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table Bavarian Nordic Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Bavarian Nordic
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Bavarian Nordic 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of Bavarian Nordic 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of Bavarian Nordic 2010-2015
Table Bavarian Nordic Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table Biota Pharmaceuticals Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Biota Pharmaceuticals
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Biota Pharmaceuticals 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of Biota Pharmaceuticals 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of Biota Pharmaceuticals 2010-2015
Table Biota Pharmaceuticals Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table Celltrion Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Celltrion
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Celltrion 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of Celltrion 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of Celltrion 2010-2015
Table Celltrion Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table Codagenix Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Codagenix
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Codagenix 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of Codagenix 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of Codagenix 2010-2015
Table Codagenix Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table Crucell Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Crucell
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Crucell 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of Crucell 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of Crucell 2010-2015
Table Crucell Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table CureVac Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of CureVac
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of CureVac 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of CureVac 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of CureVac 2010-2015
Table CureVac Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table Emergent BioSolutions Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Emergent BioSolutions
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Emergent BioSolutions 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of Emergent BioSolutions 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of Emergent BioSolutions 2010-2015
Table Emergent BioSolutions Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table Roche Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Roche
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Roche 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of Roche 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of Roche 2010-2015
Table Roche Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table GenVec Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of GenVec
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GenVec 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of GenVec 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of GenVec 2010-2015
Table GenVec Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table Gilead Sciences Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Gilead Sciences
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Gilead Sciences 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of Gilead Sciences 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of Gilead Sciences 2010-2015
Table Gilead Sciences Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table GlaxoSmithKline Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of GlaxoSmithKline
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of GlaxoSmithKline 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses) and Growth Rate of GlaxoSmithKline 2010-2015
Figure Drugs for Respiratory Syncytial Virus (RSV) Production (Doses) and United States Market Share of GlaxoSmithKline 2010-2015
Table GlaxoSmithKline Drugs for Respiratory Syncytial Virus (RSV) SWOT Analysis
Table Humabs BioMed Company Profile (Contact Information Plant Location Capacity Revenue etc)
Figure Drugs for Respiratory Syncytial Virus (RSV) Picture and Specifications of Humabs BioMed
Table Drugs for Respiratory Syncytial Virus (RSV) Capacity (Doses), Production (Doses), Price (USD/Dose), Cost (USD/Dose), Gross (USD/Dose), Revenue (M USD) and Gross Margin of Humabs BioMed 2010-2015
Figure Drugs for Respiratory Syncytial Virus

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests,  Opport

2016 Immunodiagnostic Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts for 100 Special Chemistry, Drug of Abuse, Endocrine Function, Immunoprotein, Therapeutic Drug Monitoring, and Tumor Marker Tests, Opport

  • $ 47500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-company survey from VPGMarketResearch.com contains 1,650 pages and 890 tables. The report provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ...

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

2016 Tumor Markers in 32 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Test--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Emerging Technologies, Opportunities for Suppliers

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

2016 Cancer Diagnostic Testing Analyzers and Reagents in 33 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains--Technology Trends

  • $ 47400
  • Industry report
  • October 2016
  • by Venture Planning Group

This new 33-country survey from VPGMarketResearch.com contains over 1,300 pages and 500 tables. The survey is designed to assist diagnostics industry executives, as well as companies planning to diversify ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.